2018
DOI: 10.1016/j.fertnstert.2018.07.127
|View full text |Cite
|
Sign up to set email alerts
|

RCT: tolerance of chlorhexidine gluconate versus povidone-iodine vaginal cleansing solution

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(5 citation statements)
references
References 0 publications
0
5
0
Order By: Relevance
“…There have been case reports about the adverse effect of CHX use for vaginal preparation, with issues of discomfort, including vaginal pain/burning, and complications, including desquamation, although these do not identify the concentration of CHX used. 12,24,25 A prior study comparing postoperative pain between 2% CHX and PI found no significant difference between the 2 antisepsis agents; this was a consecutive study, without randomization. 20 However, a randomized controlled trial of 134 women undergoing hysteroscopy found that vaginal pain, burning, and dysuria were increased with 4% CHX when compared with PI both immediately and at 24-48hours postoperatively.…”
Section: Discussionmentioning
confidence: 88%
See 3 more Smart Citations
“…There have been case reports about the adverse effect of CHX use for vaginal preparation, with issues of discomfort, including vaginal pain/burning, and complications, including desquamation, although these do not identify the concentration of CHX used. 12,24,25 A prior study comparing postoperative pain between 2% CHX and PI found no significant difference between the 2 antisepsis agents; this was a consecutive study, without randomization. 20 However, a randomized controlled trial of 134 women undergoing hysteroscopy found that vaginal pain, burning, and dysuria were increased with 4% CHX when compared with PI both immediately and at 24-48hours postoperatively.…”
Section: Discussionmentioning
confidence: 88%
“…There have been case reports about the adverse effect of CHX use for vaginal preparation, with issues of discomfort, including vaginal pain/burning, and complications, including desquamation, although these do not identify the concentration of CHX used 12,24,25 . A prior study comparing postoperative pain between 2% CHX and PI found no significant difference between the 2 antisepsis agents; this was a consecutive study, without randomization 20 .…”
Section: Discussionmentioning
confidence: 92%
See 2 more Smart Citations
“…We used the VSS survey tool with permission from Magdy P. Milad, MD (e‐mail communication; March 3, 2020). The tool was based on a biomedical protocol submitted to the National Institutes of Health National Library of Medicine clinical trials web site 41 before the publication of study results associated with the protocol 37 and the initiation of our study. The survey tool was an adaptation of the Patient‐Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO‐CTCAE) Measurement System that was created by the Division of Cancer Control and Population Sciences of the National Cancer Institute and is used in cancer clinical trials to detect self‐reported, symptomatic adverse events 42 .…”
Section: Methodsmentioning
confidence: 99%